These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25859996)

  • 1. Treatment interruption and directly observed treatment of multidrug-resistant tuberculosis patients in China.
    Wei XL; Yin J; Zou GY; Zhang ZT; Walley J; Harwell J; Li HT; Sun Q; Li RZ; Wang LX; Zhang XL
    Int J Tuberc Lung Dis; 2015 Apr; 19(4):413-9. PubMed ID: 25859996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for multidrug resistance among previously treated patients with tuberculosis in eastern China: a case-control study.
    Chen S; Huai P; Wang X; Zhong J; Wang X; Wang K; Wang L; Jiang S; Li J; Peng Y; Ma W
    Int J Infect Dis; 2013 Dec; 17(12):e1116-20. PubMed ID: 23916547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of treatment interruption patterns on treatment success among patients with multidrug-resistant tuberculosis in Armenia and Abkhazia.
    Bastard M; Sanchez-Padilla E; Hewison C; Hayrapetyan A; Khurkhumal S; Varaine F; Bonnet M
    J Infect Dis; 2015 May; 211(10):1607-15. PubMed ID: 25312040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between social support, treatment interruption and treatment outcome in patients with multidrug-resistant tuberculosis in China: a mixed-methods study.
    Yin J; Wang X; Zhou L; Wei X
    Trop Med Int Health; 2018 Jun; 23(6):668-677. PubMed ID: 29691959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with low cure rate of tuberculosis in remote poor areas of Shaanxi Province, China: a case control study.
    Ai X; Men K; Guo L; Zhang T; Zhao Y; Sun X; Zhang H; He G; van der Werf MJ; van den Hof S
    BMC Public Health; 2010 Mar; 10():112. PubMed ID: 20205941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from China.
    Liang L; Wu Q; Gao L; Hao Y; Liu C; Xie Y; Sun H; Yan X; Li F; Li H; Fang H; Ning N; Cui Y; Han L
    Thorax; 2012 Jul; 67(7):632-8. PubMed ID: 22403070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of treatment interruption among patients with multidrug-resistant TB (MDR TB) and association with interim and final treatment outcomes.
    Podewils LJ; Gler MT; Quelapio MI; Chen MP
    PLoS One; 2013; 8(7):e70064. PubMed ID: 23922904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Directly Observed Therapy and Treatment Outcomes in Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis.
    Yin J; Yuan J; Hu Y; Wei X
    PLoS One; 2016; 11(3):e0150511. PubMed ID: 26930287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decline in rates of acquired multidrug-resistant tuberculosis after implementation of the directly observed therapy, short course (DOTS) and DOTS-Plus programmes in Taiwan.
    Chien JY; Lai CC; Tan CK; Chien ST; Yu CJ; Hsueh PR
    J Antimicrob Chemother; 2013 Aug; 68(8):1910-6. PubMed ID: 23580558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a standardised regimen for multidrug-resistant tuberculosis in Bangladesh.
    Van Deun A; Salim MA; Das AP; Bastian I; Portaels F
    Int J Tuberc Lung Dis; 2004 May; 8(5):560-7. PubMed ID: 15137531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multidrug resistance tuberculosis - current problems].
    Kruczak K; Nizankowska-Mogilnicka E
    Pneumonol Alergol Pol; 2009; 77(3):276-83. PubMed ID: 19591099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrated review of directly observed therapy for tuberculosis in Latin America.
    Zuñiga JA
    Hisp Health Care Int; 2015; 13(1):46-54. PubMed ID: 25741933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation fidelity of hospital based directly observed therapy for tuberculosis treatment in Bhutan: mixed-method study.
    Dorji K; Lestari T; Jamtsho S; Mahendradhata Y
    BMC Public Health; 2020 Apr; 20(1):533. PubMed ID: 32306977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of anti-tuberculosis drug resistance on treatment outcome of pulmonary tuberculosis patients receiving directly observed treatment strategy in Henan Province, China].
    Wang GJ; Xu JY; Wang GB; Zhen XA; Gao SY; Du CM
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug; 29(8):527-30. PubMed ID: 17074265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multidrug resistant tuberculosis in Romania in the last years (2004-2007)--an extremely important social phenomenon].
    Marica C; Didilescu C; Chiotan D; Galie N; Tănăsescu M; Popescu-Hagen M; Popa M
    Pneumologia; 2008; 57(4):195-200. PubMed ID: 19186681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid in the treatment of MDR-TB: a retrospective clinical study.
    Xu HB; Jiang RH; Li L; Xiao HP
    Int J Tuberc Lung Dis; 2012; 16(3):358-63. PubMed ID: 22640450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss-To-Follow-Up on Multidrug Resistant Tuberculosis Treatment in Gujarat, India: The WHEN and WHO of It.
    Shringarpure KS; Isaakidis P; Sagili KD; Baxi RK
    PLoS One; 2015; 10(7):e0132543. PubMed ID: 26167891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Directly observed therapy of tuberculosis in Brazil: associated determinants and impact on treatment outcome.
    Reis-Santos B; Pellacani-Posses I; Macedo LR; Golub JE; Riley LW; Maciel EL
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1188-93. PubMed ID: 26459531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical benefit of delamanid (OPC-67683) in the treatment of multidrug-resistant tuberculosis patients in China.
    Zhang Q; Liu Y; Tang S; Sha W; Xiao H
    Cell Biochem Biophys; 2013; 67(3):957-63. PubMed ID: 23546935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.